Related content

Worldwide experience with alfuzosin and tamsulosin

By Michel M.C.   Flannery M.T.   Narayan P.  

Urology, Vol. 58, Iss. 4, 2001-10 ,pp. : 508-516

Elsevier

Access to resources Recommend Favorite

Short-term efficacy and long-term compliance/treatment failure of the α1 blocker naftopidil for patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia

By Masumori Naoya   Hashimoto Jiro   Itoh Naoki   Tsukamoto Taiji   Group The Sapporo Medical University Naftopidil Study  

Scandinavian Journal of Urology and Nephrology, Vol. 41, Iss. 5, 2007-01 ,pp. : 422-429

Informa Healthcare

Access to resources Recommend Favorite

Alfuzosin Improves Penile Erection Triggered by Apomorphine in Spontaneous Hypertensive Rats

By Mayoux E.   Ramirez J.F.   Pouyet T.   Barras M.   Arbilla S.   Galzin A.-M.  

European Urology, Vol. 45, Iss. 1, 2004-01 ,pp. : 110-116

Elsevier

Access to resources Recommend Favorite

Prostatic Tissual Distribution of Alfuzosin in Patients with Benign Prostatic Hyperplasia Following Repeated Oral Administration

By Mottet N.   Bressolle F.   Delmas V.   Robert M.   Costa P.  

European Urology, Vol. 44, Iss. 1, 2003-07 ,pp. : 101-105

Elsevier

Access to resources Recommend Favorite

First dose efficacy of alfuzosin once daily in men with symptomatic benign prostatic hyperplasia

By Marks L.S.   Roehrborn C.G.   Gittelman M.   Kim D.   Forrest J.   Jacobs S.  

Urology, Vol. 62, Iss. 5, 2003-11 ,pp. : 888-893

Elsevier

Access to resources Recommend Favorite